These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12575754)

  • 1. Mullerian inhibiting substance: an update.
    MacLaughlin DT; Donahoe PK
    Adv Exp Med Biol; 2002; 511():25-38; discussion 38-40. PubMed ID: 12575754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mullerian inhibiting substance: a gonadal hormone with multiple functions.
    Lee MM; Donahoe PK
    Endocr Rev; 1993 Apr; 14(2):152-64. PubMed ID: 8325249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vivo roles of müllerian-inhibiting substance.
    Behringer RR
    Curr Top Dev Biol; 1994; 29():171-87. PubMed ID: 7828438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Müllerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalities.
    Gustafson ML; Lee MM; Asmundson L; MacLaughlin DT; Donahoe PK
    J Pediatr Surg; 1993 Mar; 28(3):439-44. PubMed ID: 8468660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications.
    Teixeira J; Maheswaran S; Donahoe PK
    Endocr Rev; 2001 Oct; 22(5):657-74. PubMed ID: 11588147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic studies of MIS signalling in sexual development.
    Jamin SP; Arango NA; Mishina Y; Behringer RR
    Novartis Found Symp; 2002; 244():157-64; discussion 164-8, 203-6, 253-7. PubMed ID: 11990789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into mullerian inhibiting substance and its mechanism of action.
    Lane AH; Donahoe PK
    J Endocrinol; 1998 Jul; 158(1):1-6. PubMed ID: 9713320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction.
    Ingraham HA; Hirokawa Y; Roberts LM; Mellon SH; McGee E; Nachtigal MW; Visser JA
    Recent Prog Horm Res; 2000; 55():53-67; discussion 67-8. PubMed ID: 11036933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Müllerian-inhibiting substance function during mammalian sexual development.
    Behringer RR; Finegold MJ; Cate RL
    Cell; 1994 Nov; 79(3):415-25. PubMed ID: 7954809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-müllerian hormone and Sertoli cell function.
    Josso N
    Horm Res; 1992; 38 Suppl 2():72-6. PubMed ID: 1292986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic studies of the AMH/MIS signaling pathway for Müllerian duct regression.
    Jamin SP; Arango NA; Mishina Y; Hanks MC; Behringer RR
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):15-9. PubMed ID: 14656471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mullerian inhibiting substance: a fetal hormone with surgical implications.
    Hutson JM; Donahoe PK; Budzik GP
    Aust N Z J Surg; 1985 Dec; 55(6):599-605. PubMed ID: 2870703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetics and molecular pathology of anti-Mullerian hormone and its receptor].
    Picard JY; Belville C
    J Soc Biol; 2002; 196(3):217-21. PubMed ID: 12462075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gubernacular development in Müllerian inhibiting substance receptor-deficient mice.
    Bartlett JE; Lee SM; Mishina Y; Behringer RR; Yang N; Wolf J; Temelcos C; Hutson JM
    BJU Int; 2002 Jan; 89(1):113-8. PubMed ID: 11849175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The müllerian inhibitor and mammalian sexual development.
    Behringer RR
    Philos Trans R Soc Lond B Biol Sci; 1995 Nov; 350(1333):285-8; discussion 289. PubMed ID: 8570693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal sexual development in transgenic mice chronically expressing müllerian inhibiting substance.
    Behringer RR; Cate RL; Froelick GJ; Palmiter RD; Brinster RL
    Nature; 1990 May; 345(6271):167-70. PubMed ID: 2336108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High specificity of Müllerian-inhibiting substance signaling in vivo.
    Mishina Y; Whitworth DJ; Racine C; Behringer RR
    Endocrinology; 1999 May; 140(5):2084-8. PubMed ID: 10218958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.
    Donahoe PK; Clarke T; Teixeira J; Maheswaran S; MacLaughlin DT
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):37-42. PubMed ID: 14656474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development.
    Roberts LM; Visser JA; Ingraham HA
    Development; 2002 Mar; 129(6):1487-96. PubMed ID: 11880357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation in the anti-müllerian hormone gene as cause of persistent müllerian duct syndrome.
    Lang-Muritano M; Biason-Lauber A; Gitzelmann C; Belville C; Picard Y; Schoenle EJ
    Eur J Pediatr; 2001 Nov; 160(11):652-4. PubMed ID: 11760020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.